Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huofeitong is a Traditional Chinese Medicine (TCM) capsule formulation developed by Heyuan Jinyuan Green Life Co., Ltd. specifically for the treatment of chronic obstructive pulmonary disease (COPD). The drug is composed of multiple herbal extracts that work synergistically to provide anti-inflammatory, antioxidant, and immunomodulatory effects. It is primarily indicated for patients in the stable phase of COPD to improve pulmonary function, alleviate clinical symptoms such as chronic cough and dyspnea, and enhance overall quality of life. Clinical evaluations in China have focused on its ability to reduce airway inflammation and prevent acute exacerbations by modulating the production of pro-inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huofeitong.